Xconomy’s Digital Events →
Derrick Gingery is a senior writer for the Pink Sheet.
Pfizer Inc. CEO Albert Bourla said he doesn’t worry about political pressure to bring potentially the first coronavirus vaccine to market, but can’t escape feeling the weight of the world on... Read more »
Expedited programs usually shorten a US Food and Drug Administration new drug application assessment, but on average, maybe not as much as their reputation would suggest.
A Government Accountability Office (GAO) ... Read more »
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Sponsored · Video
A Fireside Chat with Fish & Richardson Principal Teresa Lavoie
© 2007-2021, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.